Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis

Abstract Background linc00261 was reported to be deregulated in many tumor groups and was significantly associated with cancer prognosis. This investigation seeks to conduct a meta-analysis to explore the link between linc00261 levels and cancer outcomes. Methods Electronic databases underwent compr...

Full description

Saved in:
Bibliographic Details
Main Authors: Xinyue He, Shixu Fang, Chen Wu, Jintong Na, Liping Zhong, Xiyu Liu
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02908-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238609017700352
author Xinyue He
Shixu Fang
Chen Wu
Jintong Na
Liping Zhong
Xiyu Liu
author_facet Xinyue He
Shixu Fang
Chen Wu
Jintong Na
Liping Zhong
Xiyu Liu
author_sort Xinyue He
collection DOAJ
description Abstract Background linc00261 was reported to be deregulated in many tumor groups and was significantly associated with cancer prognosis. This investigation seeks to conduct a meta-analysis to explore the link between linc00261 levels and cancer outcomes. Methods Electronic databases underwent comprehensive searching, and appropriate publications were filtered per the predetermined selection criteria. For each included literature, we implemented a quality assessment (NOS score) and obtained relevant data in detail. The link between linc00261 level and cancer outcomes was investigated through pooled HR and OR analysis with 95%CI. Sensitivity analysis was utilized to examine the stability and dependability of the consolidated findings. In the meantime, Begg’s test was carried out to evaluate whether there exists significant publication bias or other bias in the original literature. Results The linc00261 level exhibited reduction in the majority of tumor tissues, where enhanced linc00261 levels demonstrated substantial correlation with favorable cancer outcomes, encompassing overall survival (OS) (hazard ratio (HR): 0.497, 95% CI: 0.408–0.586), disease-free survival (DFS) (HR: 0.38, 95% CI: 0.25–0.59) and progression-free survival (PFS) (HR: 0.31, 95% CI: 0.18–0.53). Moreover, increased linc00261 levels indicated earlier TNM stages (odds ratio (OR): 0.542, 95%CI: 0.442–0.663), reduced susceptibility to distant lymph node metastasis (LNM) (OR: 0.674, 95%CI: 0.550–0.826), distant metastasis (DM) (OR: 0.579, 95%CI: 0.420–0.798), reduced tumor size (OR: 0.705, 95%CI: 0.564–0.880) and improved histological grade (OR: 0.906, 95%CI: 0.694–1.183). Sensitivity analysis outcomes suggest that individual studies demonstrate minimal influence on the comprehensive findings. The Begg’s test outcomes suggest that the original study had no significant publication or other biases. Conclusions The expression of linc00261 is decreased in many tumor tissues, high linc00261 expression indicates a satisfied prognosis of cancer. linc00261 could function as a candidate therapeutic target and an encouraging prognostic indicator for tumors.
format Article
id doaj-art-425f4cc3e1a64aacb1eacdf5306f79cf
institution Kabale University
issn 2730-6011
language English
publishDate 2025-07-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-425f4cc3e1a64aacb1eacdf5306f79cf2025-08-20T04:01:34ZengSpringerDiscover Oncology2730-60112025-07-0116112010.1007/s12672-025-02908-2Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysisXinyue He0Shixu Fang1Chen Wu2Jintong Na3Liping Zhong4Xiyu Liu5State Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityState Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityState Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityState Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityState Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityState Key Laboratory of Targeting Oncology, Guangxi Key Laboratory of Bio-targeting Theranostics, Collaborative Innovation Center for Targeting Tumor Diagnosis and Therapy, National Center for International Research of Bio-targeting Theranostics, Guangxi Medical UniversityAbstract Background linc00261 was reported to be deregulated in many tumor groups and was significantly associated with cancer prognosis. This investigation seeks to conduct a meta-analysis to explore the link between linc00261 levels and cancer outcomes. Methods Electronic databases underwent comprehensive searching, and appropriate publications were filtered per the predetermined selection criteria. For each included literature, we implemented a quality assessment (NOS score) and obtained relevant data in detail. The link between linc00261 level and cancer outcomes was investigated through pooled HR and OR analysis with 95%CI. Sensitivity analysis was utilized to examine the stability and dependability of the consolidated findings. In the meantime, Begg’s test was carried out to evaluate whether there exists significant publication bias or other bias in the original literature. Results The linc00261 level exhibited reduction in the majority of tumor tissues, where enhanced linc00261 levels demonstrated substantial correlation with favorable cancer outcomes, encompassing overall survival (OS) (hazard ratio (HR): 0.497, 95% CI: 0.408–0.586), disease-free survival (DFS) (HR: 0.38, 95% CI: 0.25–0.59) and progression-free survival (PFS) (HR: 0.31, 95% CI: 0.18–0.53). Moreover, increased linc00261 levels indicated earlier TNM stages (odds ratio (OR): 0.542, 95%CI: 0.442–0.663), reduced susceptibility to distant lymph node metastasis (LNM) (OR: 0.674, 95%CI: 0.550–0.826), distant metastasis (DM) (OR: 0.579, 95%CI: 0.420–0.798), reduced tumor size (OR: 0.705, 95%CI: 0.564–0.880) and improved histological grade (OR: 0.906, 95%CI: 0.694–1.183). Sensitivity analysis outcomes suggest that individual studies demonstrate minimal influence on the comprehensive findings. The Begg’s test outcomes suggest that the original study had no significant publication or other biases. Conclusions The expression of linc00261 is decreased in many tumor tissues, high linc00261 expression indicates a satisfied prognosis of cancer. linc00261 could function as a candidate therapeutic target and an encouraging prognostic indicator for tumors.https://doi.org/10.1007/s12672-025-02908-2linc00261CancerPrognosisMeta-analysis
spellingShingle Xinyue He
Shixu Fang
Chen Wu
Jintong Na
Liping Zhong
Xiyu Liu
Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
Discover Oncology
linc00261
Cancer
Prognosis
Meta-analysis
title Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
title_full Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
title_fullStr Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
title_full_unstemmed Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
title_short Increasing linc00261 expression may predict well cancer prognosis, based on the meta-analysis
title_sort increasing linc00261 expression may predict well cancer prognosis based on the meta analysis
topic linc00261
Cancer
Prognosis
Meta-analysis
url https://doi.org/10.1007/s12672-025-02908-2
work_keys_str_mv AT xinyuehe increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis
AT shixufang increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis
AT chenwu increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis
AT jintongna increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis
AT lipingzhong increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis
AT xiyuliu increasinglinc00261expressionmaypredictwellcancerprognosisbasedonthemetaanalysis